None listed
Conditions
Interventions
Dietary Supplement : “The intervention group consumed the customized nutritional formula together with the post-gastrectomy diet twice daily (1 pack per serving, 200 mL/pack), whereas the non-interven
Sponsors
Natural Way
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients aged 65 years or older who were histologically diagnosed with primary gastric adenocarcinoma 2. Patients classified as Stage I, II, or III based on preoperative computed tomography (CT) and intraoperative tumor-node-metastasis (TNM) staging according to the American Joint Committee on Cancer(AJCC) 8th edition, who underwent proximal gastrectomy with double tract reconstruction or total gastrectomy 3. Patients capable of oral intake after gastrectomy 4. Patients with an Eastern Cooperative Oncology Group (ECOG) performance status of 0–1 5. Individuals who voluntarily provided written informed consent to participate in this clinical study
Exclusion criteria
Exclusion criteria: 1. Patients who received preoperative neoadjuvant chemotherapy 2. Patients who developed postoperative complications of Clavien–Dindo classification grade III or higher prior to discharge 3. Patients with a history of cancer in another organ within the past 5 years, or those with a concurrent malignancy in another organ 4. Patients with a history of gastric resection surgery; however, those who have undergone endoscopic submucosal dissection (ESD) were included 5. Patients diagnosed with diabetes or currently receiving antidiabetic medication 6. Patients with chronic inflammatory diseases(Chronic obstructive pulmonary disease [COPD], chronic hepatitis, Chronic kidney disease [CKD], inflammatory bowel disease [IBD], Chron`s disease [CD], chronic pancreatitis) 7. Patients with severe comorbidities such as pulmonary or cardiac disease, or those with uncontrolled active infections 8. Patients who had consistently taken oral nutritional supplementation products for at least 4 weeks prior to surgery 9. Any other cases deemed unsuitable for the study at the discretion of the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight | — |
Secondary
| Measure | Time frame |
|---|---|
| Skeletal muscle mass and body fat mass;KOrean QUality of life in Stomach cancer patients Study group questionnaire–40(KOQUSS-40) score;European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30(EORTC QLQ-C30) score, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Stomach Cancer Module(EORTC QLQ-STO22) score | — |
Countries
Korea, Republic of
Contacts
Public ContactHyoung Il Kim
Yonsei University Health System, Severance Hospital
Outcome results
None listed